| Lancet Commission: Stem cells and regenerative medicine G Cossu, M Birchall, T Brown, P De Coppi, E Culme-Seymour, S Gibbon, ... The Lancet 391 (10123), 883-910, 2018 | 242 | 2018 |
| Behavioural and psychiatric symptoms in people with dementia admitted to the acute hospital: prospective cohort study EL Sampson, N White, B Leurent, S Scott, K Lord, J Round, L Jones The British journal of psychiatry 205 (3), 189-196, 2014 | 190 | 2014 |
| ISSCR guidelines for stem cell research and clinical translation: the 2021 update R Lovell-Badge, E Anthony, RA Barker, T Bubela, AH Brivanlou, ... Stem cell reports 16 (6), 1398-1408, 2021 | 176 | 2021 |
| A systematic review and economic evaluation of the use of tumour necrosis factor-alpha (TNF-α) inhibitors, adalimumab and infliximab, for Crohn's disease. J Dretzke, R Edlin, J Round, M Connock, C Hulme, J Czeczot, A Fry-Smith, ... Health Technology Assessment (Winchester, England) 15 (6), 1, 2011 | 164 | 2011 |
| An educational review of the statistical issues in analysing utility data for cost-utility analysis RM Hunter, G Baio, T Butt, S Morris, J Round, N Freemantle Pharmacoeconomics 33, 355-366, 2015 | 106 | 2015 |
| Is a QALY still a QALY at the end of life? J Round Journal of Health Economics 31 (3), 521 - 527, 2012 | 92 | 2012 |
| Estimating the cost of caring for people with cancer at the end of life: a modelling study J Round, L Jones, S Morris Palliative Medicine 29 (10), 899-907, 2015 | 90 | 2015 |
| An early evaluation of clinical and economic costs and benefits of implementing point of care NAAT tests for Chlamydia trachomatis and Neisseria gonorrhoea in genitourinary … KME Turner, J Round, P Horner, J Macleod, S Goldenberg, A Deol, ... Sexually transmitted infections 90 (2), 104-111, 2014 | 89 | 2014 |
| Rehabilitation in advanced, progressive, recurrent cancer: a randomized controlled trial L Jones, G FitzGerald, B Leurent, J Round, J Eades, S Davis, F Gishen, ... Journal of pain and symptom management 46 (3), 315-325. e3, 2013 | 83 | 2013 |
| Updated cost-effectiveness analysis of trastuzumab for early breast cancer: a UK perspective considering duration of benefit, long-term toxicity and pattern of recurrence PS Hall, C Hulme, C McCabe, Y Oluboyede, J Round, DA Cameron Pharmacoeconomics 29, 415-432, 2011 | 74 | 2011 |
| Screening for gestational diabetes mellitus: cost–utility of different screening strategies based on a woman’s individual risk of disease JA Round, P Jacklin, RB Fraser, RG Hughes, MA Mugglestone, RIG Holt Diabetologia 54 (2), 256-263, 2011 | 67 | 2011 |
| Mirtazapine added to SSRIs or SNRIs for treatment resistant depression in primary care: phase III randomised placebo controlled trial (MIR) DS Kessler, SJ MacNeill, D Tallon, G Lewis, TJ Peters, W Hollingworth, ... bmj 363, 2018 | 65 | 2018 |
| Cirrhosis with ascites in the last year of life: a nationwide analysis of factors shaping costs, health-care use, and place of death in England B Hudson, J Round, B Georgeson, A Pring, K Forbes, CA McCune, ... The lancet Gastroenterology & hepatology 3 (2), 95-103, 2018 | 58 | 2018 |
| Urinary tract infections in children and the risk of ESRF J Round, AC Fitzgerald, C Hulme, M Lakhanpaul, K Tullus Acta Paediatrica 101 (3), 278-282, 2012 | 52 | 2012 |
| Economic considerations in the provision of treatments for rare diseases C McCabe, R Edlin, J Round Rare diseases epidemiology, 211-222, 2010 | 42 | 2010 |
| Incorporating equity in economic evaluations: a multi-attribute equity state approach J Round, M Paulden The European Journal of Health Economics 19 (4), 489-498, 2018 | 41 | 2018 |
| Sorafenib for the treatment of advanced hepatocellular carcinoma M Connock, J Round, S Bayliss, S Tubeuf, W Greenheld, D Moore Health Technol Assess 14 (Suppl 1), 17-21, 2010 | 40 | 2010 |
| Total ankle replacement versus arthrodesis (TARVA): protocol for a multicentre randomised controlled trial AJ Goldberg, R Zaidi, C Thomson, CJ Doré, SS Skene, S Cro, J Round, ... BMJ open 6 (9), e012716, 2016 | 38 | 2016 |
| Promoting independence, health and well-being for older people: a feasibility study of computer-aided health and social risk appraisal system in primary care K Walters, K Kharicha, C Goodman, M Handley, J Manthorpe, M Cattan, ... BMC family practice 18, 1-10, 2017 | 36 | 2017 |
| Statistical alchemy: conceptual validity and mapping to generate health state utility values J Round, A Hawton PharmacoEconomics-open 1 (4), 233-239, 2017 | 32 | 2017 |
